FDA Guidance for Increasing Diversity in Clinical Research Will Soon Become Law
The latest omnibus bill includes legislation that will codify FDA guidelines for diversity in clinical trials into law. Learn more about what this means for sponsors.
Diversity Plans: Are you ready?
Diversity Plans: Are you ready? It is widely discussed that the clinical trial industry suffers from a lack of diversity in clinical trial outcomes. “Diversity” represents a wide-range of descriptions, such as race and ethnicity, sex, gender identity, age, socioeconomic status, and disability status, to name a few. The FDA has issued several sets of...